Book contents
- Patents, Human Rights, and Access to Medicines
- Patents, Human Rights, and Access to Medicines
- Copyright page
- Contents
- Acknowledgements
- 1 Introduction
- 2 Patent Policy, Access to Medicines, and the Regulatory Theory of Patent Rights
- 3 The Interface between Patent Rights and the Right to Health under International Human Rights Law
- 4 Incorporating a Model of Human Rights into the Adjudication of Pharmaceutical Patent Cases (Part One)
- 5 Incorporating a Model of Human Rights into the Adjudication of Pharmaceutical Patent Cases (Part Two)
- 6 Incorporating a Model of Human Rights into the Adjudication of Pharmaceutical Patent Cases (Part Three)
- 7 Conclusion
- Index
5 - Incorporating a Model of Human Rights into the Adjudication of Pharmaceutical Patent Cases (Part Two)
South Africa as a Case Study
Published online by Cambridge University Press: 24 February 2022
- Patents, Human Rights, and Access to Medicines
- Patents, Human Rights, and Access to Medicines
- Copyright page
- Contents
- Acknowledgements
- 1 Introduction
- 2 Patent Policy, Access to Medicines, and the Regulatory Theory of Patent Rights
- 3 The Interface between Patent Rights and the Right to Health under International Human Rights Law
- 4 Incorporating a Model of Human Rights into the Adjudication of Pharmaceutical Patent Cases (Part One)
- 5 Incorporating a Model of Human Rights into the Adjudication of Pharmaceutical Patent Cases (Part Two)
- 6 Incorporating a Model of Human Rights into the Adjudication of Pharmaceutical Patent Cases (Part Three)
- 7 Conclusion
- Index
Summary
This chapter is divided into three sections. Section 5.2 provides a brief overview of the legal framework on pharmaceutical patent law in South Africa, while Section 5.3 examines the jurisprudence on the right to health in South Africa. Section 5.4 deals with the incorporation of a model of human rights into the adjudication of disputes involving pharmaceutical patent rights by courts in South Africa. The chapter concludes with the view that the incorporation of a model of human rights does not necessarily translate to the abrogation of patent rights, it only means that the courts should not permit patent rights on pharmaceutical products to be exercised and enforced in a manner that impedes the enjoyment of the human right to health.
Keywords
- Type
- Chapter
- Information
- Patents, Human Rights, and Access to Medicines , pp. 118 - 132Publisher: Cambridge University PressPrint publication year: 2022